Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Steup

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Expert Opinion on Pharmacotherapy|June 29, 2010
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III studyRobert Buynak, Douglas Y Shapiro, Akiko Okamoto, et al.
Pain Physician|July 24, 2014
Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related painHans G Kress, E Dietlind Koch, Hristiyan Kosturski, et al.
Clinical Drug Investigation|July 1, 2010
Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyMarc Afilalo, Mila S Etropolski, Brigitte Kuperwasser, et al.
Archives of Environmental Health|January 1, 2003
Nasal function in self-reported chemically intolerant individualsGerhard Andreas Wiesmüller, Christoph Van Thriel, Achim Steup, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis painJames E Wild, Stefan Grond, Brigitte Kuperwasser, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Expert Opinion on Pharmacotherapy|June 29, 2010
Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III studyRobert Buynak, Douglas Y Shapiro, Akiko Okamoto, et al.
Pain Physician|July 24, 2014
Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related painHans G Kress, E Dietlind Koch, Hristiyan Kosturski, et al.
Clinical Drug Investigation|July 1, 2010
Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III studyMarc Afilalo, Mila S Etropolski, Brigitte Kuperwasser, et al.
Archives of Environmental Health|January 1, 2003
Nasal function in self-reported chemically intolerant individualsGerhard Andreas Wiesmüller, Christoph Van Thriel, Achim Steup, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis painJames E Wild, Stefan Grond, Brigitte Kuperwasser, et al.
Pageof 2